Publish Time: 2026-08-17 Origin: Site
For over two thousand years, ginseng (Panax ginseng) has held a central place in traditional herbal medicine. The Shennong Bencao Jing, China's oldest materia medica, ranked it among the “superior” herbs; the Bencao Gangmu later called it the “king of herbs” and recorded its use for “all deficiency syndromes.” As early as the Han dynasty, Zhang Zhongjing's Shanghan Lun paired ginseng with Baihu Tang to manage xiaoke — the condition modern medicine recognizes as diabetes — marking the earliest documented use of ginseng in glucose management.
Traditional use, however, relied on decocting whole roots, which limited the extraction of active compounds and produced highly variable results from person to person. Modern science asks sharper questions: Of the more than 200 ginsenosides in ginseng, which actually drive the benefit? Through which molecular pathways do they act on glucose metabolism? And — most importantly — can rational compounding and formulation engineering make the effect greater than ginseng extract alone?
These are the questions World-Way Biotech's Figurbalan® Compound Ginseng Powder has spent the past several years working to answer. Let's unpack the science behind this four-herb formula, starting from the AMPK metabolic regulatory network.
Modern pharmacology has established that ginseng's core mechanism for supporting glucose metabolism centers on its signature actives — ginsenosides (including Rb1, Rg1, Rg3, Re, and compound K, together with their intestinal metabolites) — and their systematic activation of the AMPK (AMP-activated protein kinase) signaling pathway.
AMPK is often described as the “master switch of cellular energy metabolism.” When the intracellular AMP/ATP ratio rises — signaling an energy deficit — AMPK is phosphorylated into its active form (p-AMPK), which then initiates a coordinated metabolic program along three axes:
p-AMPK phosphorylates the downstream target AS160 (Akt substrate of 160 kDa), triggering translocation of the glucose transporter GLUT4 from intracellular vesicles to the plasma membrane of skeletal muscle and fat cells. Once anchored at the membrane, GLUT4 efficiently transports glucose from the bloodstream into cells, helping maintain healthy blood glucose levels.
p-AMPK enters the nucleus and phosphorylates the transcriptional coactivator CRTC2 (CREB-regulated transcription coactivator 2), sequestering it in the cytoplasm. This blocks CREB-driven transcription of the key gluconeogenic enzymes PEPCK (phosphoenolpyruvate carboxykinase) and G6Pase (glucose-6-phosphatase), helping to moderate the liver's endogenous glucose output.
p-AMPK phosphorylates and inactivates ACC (acetyl-CoA carboxylase), lowering malonyl-CoA levels and relieving inhibition of fatty acid β-oxidation. In parallel, p-AMPK downregulates SREBP-1c (sterol regulatory element-binding protein-1c), tempering hepatic de novo lipogenesis. Healthier lipid metabolism reduces the interference of ectopic fat with insulin signaling and indirectly supports peripheral insulin sensitivity.
Research indicates that ginsenosides — particularly Rb1 and compound K — activate AMPK through two upstream kinase pathways, LKB1–AMPK and CaMKKβ–AMPK [1,2]. This dual-entry mechanism gives ginsenosides a distinct advantage: even in insulin-resistant states where the LKB1 pathway is impaired, the CaMKKβ pathway can still independently trigger AMPK activation.
Building on the ginsenoside–AMPK core pathway, Figurbalan® Compound Ginseng Powder adds three auxiliary metabolic axes to form a “1+3” multi-target network:
Auxiliary Axis 1 — Moderating intestinal carbohydrate absorption.The Malus hupehensis leaf in the formula is rich in phloridzin (≥5.0% by HPLC), a natural dual inhibitor of the SGLT1 and GLUT2 glucose transporters. At the intestinal brush-border membrane, phloridzin competes with glucose for SGLT1 binding sites, moderating the proportion of dietary carbohydrate absorbed and supporting healthy post-meal glucose metabolism [3]. This mechanism is complementary — rather than redundant — with acarbose's α-glucosidase inhibition: phloridzin blocks transport while acarbose blocks breakdown, moderating post-meal glucose at two distinct nodes.
Auxiliary Axis 2 — Supporting pancreatic β-cell health.Astragaloside IV from Astragalus membranaceus activates the Nrf2/ARE antioxidant-response pathway, upregulating superoxide dismutase (SOD) and glutathione peroxidase (GPx) to reduce oxidative stress on pancreatic β-cells. It also raises the Bcl-2/Bax ratio, protecting β-cells from programmed cell death through the mitochondrial apoptosis pathway and helping to preserve the long-term reserve of endogenous insulin production [4].
Auxiliary Axis 3 — Supporting a balanced inflammatory response.Insulin resistance is closely associated with chronic, low-grade systemic inflammation. Hesperidin from Citrus reticulata peel inhibits IκBα phosphorylation and blocks nuclear translocation of the NF-κB p65 subunit, lowering transcription of pro-inflammatory cytokines and chemokines such as TNF-α, IL-6, and MCP-1 [5]. Modulating inflammatory signaling in adipose and liver tissue supports efficient tyrosine phosphorylation of insulin receptor substrate-1 (IRS-1), helping to maintain healthy insulin signaling.
Together, these four metabolic axes — AMPK activation, moderating intestinal carbohydrate absorption, β-cell support, and a balanced inflammatory response — act on distinct nodes of glucose homeostasis while reinforcing one another through the AMPK hub. This integration is the fundamental advantage that distinguishes Figurbalan® Compound Ginseng Powder from single-compound extracts.
World-Way Biotech's R&D center evaluated the α-amylase inhibitory activity of Figurbalan® Compound Ginseng Powder against single-ingredient controls. The compound formula showed a clear dose-response relationship, whereas pure ginseng extract displayed almost no α-amylase inhibition at the same concentrations — a difference attributable to the synergistic action of polyphenols such as phloridzin and hesperidin on carbohydrate-digesting enzymes.
In the α-glucosidase assay, Figurbalan®'s IC50 was approximately 40% that of pure ginseng extract, confirming a genuine synergistic effect rather than simple additive stacking [6].
In a type 2 diabetes mouse model induced by a high-fat, high-sugar diet combined with streptozotocin (STZ), mice gavaged with Figurbalan® Compound Ginseng Powder (0.6 g/kg/day) for 4 weeks showed, relative to the model control group:
• Fasting blood glucose reduced by 27.92% (p<0.01)
• Oral glucose tolerance test (OGTT) area under the curve (AUC) reduced by 20.86% (p<0.05)
• Serum insulin significantly reduced (p<0.05), indicating improved endogenous insulin sensitivity
• Hematoxylin–eosin (H&E) staining of islet tissue showed intact morphology with clear boundaries and markedly more β-cells than the model control group, which displayed the characteristic islet atrophy and β-cell vacuolar degeneration of diabetic pathology [6]
These findings are protected by a granted Chinese invention patent (Patent No. ZL 2023 1 1359113.6), confirming the originality of the Figurbalan® formulation design at the intellectual-property level.
In a randomized controlled human study conducted by an independent third-party laboratory, participants took Figurbalan® Compound Ginseng Powder (1 g per serving) 30 minutes before standard meals, twice daily, for 4 weeks. Key findings:
• Post-meal (2-hour) blood glucose excursion relative to the fasting baseline reduced by an average of 38.67%
• Post-meal (2-hour) blood glucose reduced by an average of 13.09%
• Fasting blood glucose reduced by an average of 6.81% [6]
For context: a randomized controlled clinical study of Korean red ginseng published in the Journal of Ginseng Research (2026) reported an average fasting blood glucose reduction of 3–5% after 8 weeks of supplementation [7]. The Figurbalan® third-party study observed a 6.81% average fasting glucose reduction over a 4-week period. These are separate studies with different protocols and are not a direct head-to-head comparison; nevertheless, they illustrate the rationale for a multi-component approach to supporting healthy glucose metabolism.
Worth particular note: a 2019 systematic review published in Molecules examined high-quality research on ginseng and glucose metabolism from 2000–2019 and concluded that “the low oral bioavailability of ginsenosides is a key bottleneck limiting their clinical translation,” recommending “compound formulations or advanced delivery technologies to improve the in vivo absorption and metabolism of ginseng actives” [8]. Figurbalan®'s multi-component, multi-target, multi-node design is a systematic, engineering-driven realization of precisely this recommendation.
Founded in 1992, World-Way Biotech has spent more than three decades in the botanical extract industry and is a drafting unit of China's national standard Terminology of Plant Extracts (GB/T 43808-2024). Every batch of Figurbalan® Compound Ginseng Powder is backed by a rigorous end-to-end technical system:
Raw-material traceability and precise quality control.The ginseng is sourced from World-Way's partner cultivation bases, with full control from germplasm identification through harvest timing. Each incoming batch is verified by HPLC fingerprinting to confirm species authenticity and active-compound distribution, while GC-MS and ICP-MS screen for 300+ pesticide residues and heavy metals to Eurofins-aligned international standards — ensuring raw materials are traceable, quantifiable, and verifiably safe.
Ultrasound-assisted moderate-temperature extraction.Unlike traditional ginseng decoction, Figurbalan® uses ultrasound-assisted moderate-temperature extraction. Ultrasonic cavitation efficiently disrupts cell walls at gentle temperatures, promoting full release of ginsenosides and phloridzin while avoiding the irreversible degradation of heat-sensitive components such as Rg3 and malonyl ginsenosides. Low-temperature extraction also preserves the antioxidant activity of polyphenols — a process advantage unattainable with conventional water decoction.
Precision formulation processing.The extract undergoes vacuum concentration followed by spray drying, with precise control of inlet and outlet temperatures and atomizer speed to ensure uniform particle size, excellent flowability, and solubility. Final three-dimensional mixing achieves molecular-level uniform distribution of all four ingredients — ginseng, astragalus, Malus hupehensis leaf, and citrus peel — in every batch. Batch-to-batch phloridzin content is held within a very tight tolerance, delivering mathematical-grade consistency for finished products.
Comprehensive certification matrix.ISO 9001, FSSC 22000, HACCP, KOSHER, and HALAL certifications cover market-entry requirements across Europe, North America, the Middle East, Southeast Asia, and Japan and Korea.
For finished-product development teams, we recommend the following formulation approaches: solid beverages — 1–2 g Figurbalan® per serving, combined with soluble dietary fiber such as resistant dextrin or inulin to support satiety and glucose buffering; capsules — 500 mg per capsule, 2 capsules per serving, taken with warm water 15–30 minutes before meals; functional foods — combined with cinnamon extract (supporting healthy insulin sensitivity) or mulberry leaf DNJ (complementary α-glucosidase support) to build a “multi-pathway glucose-support matrix.”
As the global blood-sugar-support supplement market continues to expand, consumers increasingly seek “science-validated natural solutions” over vague trust in traditional herbs. With clearly specified actives (phloridzin ≥5.0% by HPLC), a traceable evidence chain (in vitro → preclinical → human), and end-to-end quality control, World-Way Biotech's Figurbalan® Compound Ginseng Powder gives brand partners a complete chain of trust from ingredient to finished product.
If you are looking for a glucose-management ingredient solution that can withstand peer review, visit cn.world-way.net or contact our technical team directly by email to request samples and the complete efficacy data package. We look forward to discussing with your R&D team how Figurbalan®'s formulation science can bring measurable competitive advantage to your next flagship formula.
References
[1] Jeong KJ, et al. AMPK activation by ginsenosides: molecular mechanisms and therapeutic implications. J Ginseng Res. 2020.
[2] Shen L, Haas M, Wang DQ, et al. Ginsenoside Rb1 increases insulin sensitivity by activating AMP-activated protein kinase in male rats. Physiol Rep. 2015.
[3] Ghezzi C, Loo DDF, Wright EM. Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2. Diabetologia. 2018.
[4] Liu P, et al. Astragaloside IV protects pancreatic β-cells via Nrf2-mediated antioxidant defense. J Ethnopharmacol. 2021.
[5] Parhiz H, et al. Hesperidin exerts anti-inflammatory effects via NF-κB pathway suppression. Phytother Res. 2015.
[6] World-Way Biotech R&D Center. Figurbalan® Compound Ginseng Powder: in vitro enzyme activity, preclinical efficacy, and third-party human clinical trial report. Internal research data. 2024.
[7] Choi JS, et al. Clinical randomized controlled trial and network pharmacological analysis of blood glucose regulation by Korean red ginseng. J Ginseng Res. 2026.
[8] Yoon SJ, et al. Review of ginseng anti-diabetic studies. Molecules. 2019;24(24):4501.